Clinical Trial Update: The Effect of Addition of Metformin In Obese Non- Diabetic Patients With Heart Failure With Preserved Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the addition of metformin in obese, non-diabetic patients with heart failure with preserved ejection fraction (diastolic dysfunction…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Dysfunction
• Heart Failure with Preserved Ejection Fraction
• Obesity

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Sara ElAdawy | Conditions: Diastolic Dysfunction, Obesity | Phase 2 | Status: UNKNOWN